March 2019
Finish Cancer Through Research
Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 120 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.
Phase 1 trials advance promising new immunotherapies
Phase 1 studies are the springboard for advancing new cancer treatments.  Providence Cancer Institute is often able to offer patients first-in-human clinical trials of immunotherapies and other novel cancer therapies through phase 1 studies, including these two recently opened studies:

All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types .
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.